Mirae Asset Global Investments Co., Ltd. Dynavax Technologies Corp Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,740 shares of DVAX stock, worth $60,529. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,740
Previous 3,908
21.29%
Holding current value
$60,529
Previous $43,000
20.93%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DVAX
# of Institutions
275Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$280 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$160 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$118 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$106 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$98.2 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.62B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...